SSJ Synopsis.pdf

JUSTIFICATION FOR SOLE SOURCE PROCUREMENT (OPEN MARKET OR GSA)

UNDER $250,000

Sole source acquisitions may be used on a limited basis and only when the Contracting Officer’s Representative (COR)/Program Official has provided sufficient justification and the Contracting Officer has determined that the circumstances warrant such action. The content for a justification must contain detailed facts and rationale to justify the sole source acquisition. Soliciting from a single source must be done in accordance with FAR 13.106-1(b) or 8.405-6. At a minimum, the following information must be included:

Identification of Program Office, Contracting Activity, and Proposed Requirement, Justification and Program Office Certification:

A. Program Office:

Global Immunization Division Office of the Director 1600 Clifton Rd, Building 24, Mailstop, MS H24-2 Centers for Disease Control and Prevention Atlanta, GA 30329

B. Contracting Activity:

Centers for Disease Control and Prevention Office of Financial Resources Acquisition Branch Click here to enter text.

C. Identification of Requirement:

1. Nature of Action to be Approved by Contracting Officer:

a. Sole source acquisition of: Services to develop 2021 – 2030 Global Immunization Strategic Framework

b. Procurement Request (PR) Number (if available): 00HCBBD1-2020-40669

2. Proposed Vendor and Estimated Procurement Amount (if available):

a. Proposed Vendor: Deloitte Consulting

b. Estimated Procurement Amount:

3. Is the requirement on GSA Schedule? ☐ Yes ☒ No

If yes, provide schedule number: Click here to enter text.

Rev. 5/14/19

D. Justification:

1. The justification for this non-competitive action is

☒ In accordance with FAR 13.106-1(b)(1), “only one source [is] reasonably available” which states that, “For purchases not exceeding the simplified acquisition threshold. (i) Contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name or industrial mobilization). (ii) Where a single source is identified to provide a portion of a purchase because that portion of the purchase specifies a particular brand-name item, the documentation in paragraph (b)(1)(i) of this section only applies to the portion of the purchase requiring brand-name item. The documentation should state it is covering only the portion of the acquisition which is brand- name.”

☐ Urgency

☐ Exclusive licensing agreements/Proprietary data

☐ Brand name required

☐ Industrial mobilization

☒ Other (e.g., compatibility, space issues, continuity, compatibility, etc.)

☐ In accordance with FAR 8.405-6 “Limiting Sources” which states that, “the only circumstances that may justify the action are – (A) An urgent and compelling need exists, and following the procedures would result in unacceptable delays; (B) Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized; or (C) In the interest of economy and efficiency, the new work is a logical follow-up to an original Federal Supply Schedule order provided that the original order was placed in accordance with the applicable Federal Supply Schedule ordering procedures. The original BPA must not have been previously issued under sole-source or limited-sources procedures.”

☐ Urgency

☐ Only One Source

☐ Logical Follow Up

☐ Brand name required

2. Other facts supporting sole source procurement:

a. What can this product/service do that other products/services cannot do?

Deloitte conducted the Phase 1 development process for CDC’s next strategic framework for global immunization (2021-2030). Phase 1 involved consultation and data collection across multiple Centers, Institutes, and Offices (CIOs) across CDC, as well as leading a retreat with CDC’s Global Immunization Division leadership and working with the CDC’s Global Immunization Division project team to assess performance of the previous strategic framework, the landscape of global immunization activities across the agency, future priorities, and the agency’s comparative advantage in light of global trends. The proposed task is to complete Phases 2 of the 2021 – 2030 Global Immunization Strategic Framework (GISF) development process (December 2019-April 2020), which builds on the inputs and outputs from Phase 1. Successfully completing Phase 2 requires all of the explicit and tacit knowledge acquired during Phase 1 from CIOs across the agency about global immunization activities, capabilities, and priorities. It would be inefficient and require duplicative additional time from CDC staff across the agency to provide an alternative vendor with all of the information collected during Phase 1 again to enable execution of Phase 2; use of the same vendor is a logical follow-up to reduce costs to CDC to complete the follow-on phases of GISF development. Having successfully

Rev. 5/14/19 carried out Phase 1 activities, the vendor has successfully completed all of the expected outputs and outcomes to date. Given their successful performance during Phase 1, and the dependence of Phase 2 on the information collected during Phase 1, the proposed vendor is the only offeror known to us with the knowledge and experience required to implement Phase 2of the CDC GISF development process.

The proposed vendor also has deep knowledge and experience of CDC as a result of successfully completing similar work for other CDC Centers and Divisions.

b. What other products/services were considered and why did they not meet the need?

Given the dependence of Phase 2 of GISF development on the services performed during Phase 1, and the increased costs to CDC that would be incurred if an alternative vendor was used for Phase 2, no alternative vendors were considered. In addition, other vendors might have similar generic offerings (i.e., strategic planning, stakeholder consultation, document design) but they have less specific knowledge of CDC as an organization, and less of a track record of successfully navigating the organization to produce such plans.

3. Program Office efforts to seek potential offerors:

As stated previously, the service requires a specialized set of knowledge and experience developed by conducting Phase 1 2021-2030 GISF development process. The vendor is the only offeror with the unique knowledge and experience; therefore, further search will not be conducted

E. Program Office Certification:

I have reviewed this sole source justification and certify the justification is true and accurate to the best of my knowledge and adequate to support other than full and open competition.

Center/Institute/Office COR/Program Official Name/Title: Taiwo Abimbola - Economist

Center/Institute/Office COR/Program Official Signature:

Certification Date: April 30, 2021

F. Contracting Office Certification:

I have fully relied on the information provided herein and hereby certify that this justification is accurate and complete to the best of my knowledge and belief:

Contracting Officer Name:

Contracting Officer Signature:

Certification Date: